Source link : https://www.newshealth.biz/health-news/first-glp-1-generic-launched-52-intermittent-fasting-win-whos-ozempic-warning/
Teva Pharmaceuticals announced the launch of the first authorized GLP-1 receptor agonist generic of liraglutide 1.8 mg injection (Victoza) in the U.S. Combining 3-mg liraglutide (Saxenda) with exercise yielded more weight loss compared with either alone, and preserved bone health. (JAMA Network Open) The Environmental Protection Agency’s rule limiting per- and polyfluoroalkyl substances (PFAS) — […]
Author : News Health
Publish date : 2024-06-25 16:59:22
Copyright for syndicated content belongs to the linked Source.
Categories